GlassScriptPhysician profile
Feven Getaneh
NPI 1124555297
$3,964.83
in general payments reported to CMS, 2019-2025
11 companies · $768 in 2025
The $768 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,158 · 2023: $889 · 2024: $1,150 · 2025: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,807.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $956.88 | 2022 | |
| Coloplast Corp | $807.11 | 2023-2025 | Altis |
| Boston Scientific Corporation | $788.01 | 2022-2025 | Upsylon, Solyx Sis System, Advantage System |
| Axonics, INC. | $657.12 | 2024 | Axonics, Bulkamid |
| Femselect INC. | $332.75 | 2025 | Enplace |
| Coopersurgical, INC. | $115.76 | 2024 | Wallach Cryosurgical Equipment |
| Abbvie INC. | $108.34 | 2023 | |
| Caldera Medical, INC | $101.91 | 2025 | |
| Myovant Sciences INC. | $59.25 | 2022 | |
| Valencia Technologies Corporation | $20.93 | 2023 | Ecoin Device Kit |
| Astellas Pharma US INC | $16.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Feven Getaneh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.